Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Germany’s Merck Opens R&D Center In India

by Jean-François Tremblay
January 10, 2011 | A version of this story appeared in Volume 89, Issue 2

[+]Enlarge
Credit: Merck KGaA
Merck’s new R&D center in Mumbai.
Credit: Merck KGaA
Merck’s new R&D center in Mumbai.

Merck KGaA has inaugurated an R&D center in Mumbai. Occupying 1,700 m2, the center will provide application development support for the entire Merck product range, “from drug discovery to automobile and decorative paints.” The center will incorporate technical capabilities stemming from its acquisition of Millipore last year, the firm adds. Separately, Merck has acquired Beijing Skywing Technology, a supplier of cell-culture media products and bioreactors for the Chinese biopharmaceutical industry. The purchase, for about $18 million, strengthens the former Millipore business in China, Merck says.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.